1. Home
  2. DNUT vs FDMT Comparison

DNUT vs FDMT Comparison

Compare DNUT & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krispy Kreme Inc.

DNUT

Krispy Kreme Inc.

HOLD

Current Price

$3.67

Market Cap

585.5M

ML Signal

HOLD

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

HOLD

Current Price

$10.40

Market Cap

479.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNUT
FDMT
Founded
1937
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
585.5M
479.9M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
DNUT
FDMT
Price
$3.67
$10.40
Analyst Decision
Hold
Strong Buy
Analyst Count
5
7
Target Price
$4.15
$31.71
AVG Volume (30 Days)
1.9M
650.1K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.79
EPS
N/A
N/A
Revenue
$1,522,616,000.00
$85,209,000.00
Revenue This Year
$0.55
N/A
Revenue Next Year
$3.59
$70.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
230194.60
52 Week Low
$2.58
$3.03
52 Week High
$5.73
$12.34

Technical Indicators

Market Signals
Indicator
DNUT
FDMT
Relative Strength Index (RSI) 50.19 60.76
Support Level $3.09 $9.71
Resistance Level $3.87 $10.70
Average True Range (ATR) 0.24 0.50
MACD -0.02 0.02
Stochastic Oscillator 13.61 83.57

Price Performance

Historical Comparison
DNUT
FDMT

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet-treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations world-wide. It derives maximum revenue from the U.S. segment.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

Share on Social Networks: